摘要
Abstract
Objective: To explore a effective, safe and convenient treatment on neonatal hyperbilirubinemia. Methods:120 neonates with hyperbilirubinemia were randomly divided into two groups as a control group and a treatment group. Blue light irradiation and other conventional therapy for the control group, an additional treatment of taking phenobarbital, tetralogy of viable bifidobacterium tablets, and montmorillonite powder on the basis of conventional treatment for the treatment group were done. The effective rates, bilirubin levels posttreatment, adverse reaction rates between two groups were compared. Results: There was statistically significant difference in effective rates between the two groups, 96.7%for the treatment group and 80%for the control group respectively. The drop-out values of the average daily bilirubin were (58.91 ± 22.40) umol/L for the treatment group and (38.61±21.63) umol/L for the control group respectively, also with statistically significant difference. There were many adverse reactions like diarrhea, fever, tetter etc. in control group, while not obvious adverse reactions except several drowsiness and constipation in treatment group. Conclusion: The combined application of phenobarbital, tetralogy of viable bifidobacterium tablets, and montmorillonite powder could be effective, economical and convenient on neonatal hyperbilirubinemia关键词
苯巴比妥/双歧杆菌四联活菌片/蒙脱石散/新生儿高胆红素血症Key words
phenobarbital/tetralogy of viable bifidobacterium tablets/montmorillonite powder/neonatal hyperbilirubinemia分类
医药卫生
